Avoid With Locoregional Analgesia Persistant Postoperative Pain In Children

Launched by NANTES UNIVERSITY HOSPITAL · Feb 14, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating whether a special pain management technique called locoregional analgesia can help prevent ongoing pain in children after orthopedic surgery. Ongoing pain, known as persistent postoperative pain, can occur even after minor surgeries and can last for months. In this study, some children will receive locoregional analgesia, which numbs a specific area of the body before surgery, while others will receive standard pain relief during surgery. Researchers will then compare the occurrence of persistent pain in both groups at 3, 6, and 12 months after the surgery.

To participate in this trial, children need to be between 5 and 15 years old and scheduled for certain types of orthopedic surgery at CHU Nantes. They must also be able to communicate their pain levels and have no medical conditions that would prevent them from receiving locoregional analgesia. Parents will need to give their consent for their child to be included in the study. Participants can expect to receive careful monitoring and support throughout the trial, and the findings could help improve pain management for children undergoing surgery in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 5 years old and 15 years and 3 months
• • Traumatologic orthopedic surgery in CHU Nantes
• • Conscious patient (Glasgow score =15)
• • Patients able to give a verbal assessment of their pain
• • No contraindication to Locoregional Analgesia
• • Patient member of the social security system
• • Oral consent of the patient
• • Signed consent of one of the two holders of parental authority
• Exclusion Criteria:
• • Refusal to participate of the patient or one of the two holders of parental authority
• • Neurologic deficit of the operated limb before intervention
• • Ischemia of the operated limb before intervention
• • Polytraumatized patient
• • Allergia to Carbocaïne
• • Atrioventricular conduction disorders
• • Patient included in an other study about analgesia
• • Anticoagulant treatment
• • Uncontrolled epilepsy despite treatment
• • Porphyria